SEMA3C drives cancer growth by transactivating multiple receptor tyrosine kinases via Plexin B1

E-ISSN： 1757-4684|10|2|219-238

ISSN： 1757-4676

Source： EMBO Molecular Medicine, Vol.10, Iss.2, 2018-02, pp. : 219-238

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Semaphorin‐3C signals through Neuropilin‐1 and PlexinD1 receptors to inhibit pathological angiogenesis

EMBO Molecular Medicine, Vol. 1757-4676, Iss. 10, 2015-10 ,pp. : 1267-1284

John Wiley & Sons Inc

Access to resources Recommend Favorite

Semaphorin‐3C signals through Neuropilin‐1 and PlexinD1 receptors to inhibit pathological angiogenesis

EMBO Molecular Medicine, Vol. 7, Iss. 10, 2015-10 ,pp. : 1267-1284

John Wiley & Sons Inc

Access to resources Recommend Favorite

Targeting the insulin‐like growth factor‐1 receptor by picropodophyllin for lung cancer chemoprevention

Molecular Carcinogenesis, Vol. 54, Iss. S1, 2015-06 ,pp. : E129-E137

John Wiley & Sons Inc

Access to resources Recommend Favorite

Zbed3 contributes to malignant phenotype of lung cancer via regulating β‐catenin and P120‐catenin 1

Molecular Carcinogenesis, Vol. 54, Iss. S1, 2015-06 ,pp. : E138-E147

John Wiley & Sons Inc

Access to resources Recommend Favorite

Piperine, an alkaloid from black pepper, inhibits growth of human colon cancer cells via G1 arrest and apoptosis triggered by endoplasmic reticulum stress

Molecular Carcinogenesis, Vol. 899-1987, Iss. 10, 2015-10 ,pp. : 1070-1085

John Wiley & Sons Inc

Access to resources Recommend Favorite